Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 171

1.

Nanoparticle-based therapeutic delivery of prohibitin to the colonic epithelial cells ameliorates acute murine colitis.

Theiss AL, Laroui H, Obertone TS, Chowdhury I, Thompson WE, Merlin D, Sitaraman SV.

Inflamm Bowel Dis. 2011 May;17(5):1163-76. doi: 10.1002/ibd.21469. Epub 2010 Sep 24.

2.

Prohibitin is a novel regulator of antioxidant response that attenuates colonic inflammation in mice.

Theiss AL, Vijay-Kumar M, Obertone TS, Jones DP, Hansen JM, Gewirtz AT, Merlin D, Sitaraman SV.

Gastroenterology. 2009 Jul;137(1):199-208, 208.e1-6. doi: 10.1053/j.gastro.2009.03.033. Epub 2009 Mar 25.

3.

Nrf2 is not required for epithelial prohibitin-dependent attenuation of experimental colitis.

Kathiria AS, Butcher MA, Hansen JM, Theiss AL.

Am J Physiol Gastrointest Liver Physiol. 2013 May 15;304(10):G885-96. doi: 10.1152/ajpgi.00327.2012. Epub 2013 Mar 14.

4.

Chitosan oligosaccharide as potential therapy of inflammatory bowel disease: therapeutic efficacy and possible mechanisms of action.

Yousef M, Pichyangkura R, Soodvilai S, Chatsudthipong V, Muanprasat C.

Pharmacol Res. 2012 Jul;66(1):66-79. doi: 10.1016/j.phrs.2012.03.013. Epub 2012 Mar 28.

PMID:
22475725
5.

Prohibitin inhibits tumor necrosis factor alpha-induced nuclear factor-kappa B nuclear translocation via the novel mechanism of decreasing importin alpha3 expression.

Theiss AL, Jenkins AK, Okoro NI, Klapproth JM, Merlin D, Sitaraman SV.

Mol Biol Cell. 2009 Oct;20(20):4412-23. doi: 10.1091/mbc.E09-05-0361. Epub 2009 Aug 26.

6.

Protective role of 1,25(OH)2 vitamin D3 in the mucosal injury and epithelial barrier disruption in DSS-induced acute colitis in mice.

Zhao H, Zhang H, Wu H, Li H, Liu L, Guo J, Li C, Shih DQ, Zhang X.

BMC Gastroenterol. 2012 May 30;12:57.

7.

Fluoxetine inhibits NF-κB signaling in intestinal epithelial cells and ameliorates experimental colitis and colitis-associated colon cancer in mice.

Koh SJ, Kim JM, Kim IK, Kim N, Jung HC, Song IS, Kim JS.

Am J Physiol Gastrointest Liver Physiol. 2011 Jul;301(1):G9-19. doi: 10.1152/ajpgi.00267.2010. Epub 2011 Mar 24.

8.
9.

Ursolic acid inhibits nuclear factor-κB signaling in intestinal epithelial cells and macrophages, and attenuates experimental colitis in mice.

Chun J, Lee C, Hwang SW, Im JP, Kim JS.

Life Sci. 2014 Aug 6;110(1):23-34. doi: 10.1016/j.lfs.2014.06.018. Epub 2014 Jun 30.

PMID:
24992474
10.

Novel guggulsterone derivative GG-52 inhibits NF-kappaB signaling in intestinal epithelial cells and attenuates acute murine colitis.

Kim JM, Kang HW, Cha MY, Yoo D, Kim N, Kim IK, Ku J, Kim S, Ma SH, Jung HC, Song IS, Kim JS.

Lab Invest. 2010 Jul;90(7):1004-15. doi: 10.1038/labinvest.2010.54. Epub 2010 Mar 1.

11.

Anti-inflammatory mechanism of metformin and its effects in intestinal inflammation and colitis-associated colon cancer.

Koh SJ, Kim JM, Kim IK, Ko SH, Kim JS.

J Gastroenterol Hepatol. 2014 Mar;29(3):502-10.

PMID:
24716225
12.

A novel NF-κB inhibitor, dehydroxymethylepoxyquinomicin, ameliorates inflammatory colonic injury in mice.

Funakoshi T, Yamashita K, Ichikawa N, Fukai M, Suzuki T, Goto R, Oura T, Kobayashi N, Katsurada T, Ichihara S, Ozaki M, Umezawa K, Todo S.

J Crohns Colitis. 2012 Mar;6(2):215-25. doi: 10.1016/j.crohns.2011.08.011. Epub 2011 Sep 21.

PMID:
22325176
13.

Fexofenadine regulates nuclear factor-κB signaling and endoplasmic reticulum stress in intestinal epithelial cells and ameliorates acute and chronic colitis in mice.

Koh SJ, Kim JW, Kim BG, Lee KL, Chun J, Kim JS.

J Pharmacol Exp Ther. 2015 Mar;352(3):455-61. doi: 10.1124/jpet.114.217844. Epub 2014 Dec 23.

14.

Prohibitin attenuates colitis-associated tumorigenesis in mice by modulating p53 and STAT3 apoptotic responses.

Kathiria AS, Neumann WL, Rhees J, Hotchkiss E, Cheng Y, Genta RM, Meltzer SJ, Souza RF, Theiss AL.

Cancer Res. 2012 Nov 15;72(22):5778-89. doi: 10.1158/0008-5472.CAN-12-0603. Epub 2012 Aug 6.

15.

Enalapril inhibits nuclear factor-κB signaling in intestinal epithelial cells and peritoneal macrophages and attenuates experimental colitis in mice.

Lee C, Chun J, Hwang SW, Kang SJ, Im JP, Kim JS.

Life Sci. 2014 Jan 24;95(1):29-39. doi: 10.1016/j.lfs.2013.11.005. Epub 2013 Nov 15.

PMID:
24239644
16.
17.

R-spondin1, a novel intestinotrophic mitogen, ameliorates experimental colitis in mice.

Zhao J, de Vera J, Narushima S, Beck EX, Palencia S, Shinkawa P, Kim KA, Liu Y, Levy MD, Berg DJ, Abo A, Funk WD.

Gastroenterology. 2007 Apr;132(4):1331-43. Epub 2007 Feb 6.

PMID:
17408649
18.

Berberine promotes recovery of colitis and inhibits inflammatory responses in colonic macrophages and epithelial cells in DSS-treated mice.

Yan F, Wang L, Shi Y, Cao H, Liu L, Washington MK, Chaturvedi R, Israel DA, Cao H, Wang B, Peek RM Jr, Wilson KT, Polk DB.

Am J Physiol Gastrointest Liver Physiol. 2012 Mar 1;302(5):G504-14. doi: 10.1152/ajpgi.00312.2011. Epub 2011 Dec 15.

19.

Drug-loaded nanoparticles targeted to the colon with polysaccharide hydrogel reduce colitis in a mouse model.

Laroui H, Dalmasso G, Nguyen HT, Yan Y, Sitaraman SV, Merlin D.

Gastroenterology. 2010 Mar;138(3):843-53.e1-2. doi: 10.1053/j.gastro.2009.11.003. Epub 2009 Nov 10.

PMID:
19909746
20.

Glutamine therapy improves outcome of in vitro and in vivo experimental colitis models.

Xue H, Sufit AJ, Wischmeyer PE.

JPEN J Parenter Enteral Nutr. 2011 Mar;35(2):188-97. doi: 10.1177/0148607110381407.

PMID:
21378248
Items per page

Supplemental Content

Write to the Help Desk